Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The Head-to-Head Trial: SURMOUNT-5 The clearest answer to which drug produces more weight loss came from SURMOUNT-5, a Phase 3b controlled trial comparing tirzepatide directly against semaglutide in adults with obesity
Clinicians should evaluate individual risk factors, comorbidities, and contraindications when choosing patients for treatment, balancing possible benefits with associated dangers
Its important to consult with your healthcare provider to determine if Semaglutide GLP-1 is the right option for you, weighing all potential benefits and risks
In person in Aptos or delivered to your door.
US$ 22.78
/assets/production/practices/3280152d22c7599df4208c7f13bd6f106ba2a939/images/2788238.jpeg)
US$ 22.97
US$ 25.26
.png)
US$ 24.69
